Teplizumab

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Description of Patients With Type 1 Diabetes Treated With Teplizumab

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"